UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
Form 10-Q
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.
For the quarterly period ended March 31, 2009.
or
[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT.
For the transition period from to
----------- ----------
Commission File No. -- 0-16335
Ridgefield Acquisition Corp.
-----------------------------------------------------------------
(Exact Name of Small Business Issuer as Specified in its Charter)
Nevada 84-0922701
- ------------------------------- ----------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
1 North Federal Highway, Suite 201 Boca Raton, Florida 33432
------------------------------------------------------------
(Address of Principal Executive Office) (Zip Code)
(561) 362-5385
--------------------------------------------------
(Registrant's telephone number including area code)
Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the past 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
[X] Yes [ ] No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation S-T
(Section 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).
[X] Yes [ ] No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company.
Large accelerated filer [ ] Accelerated filer [ ]
Non-accelerated filer [ ] Smaller reporting company [X]
Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act).
[X] Yes [ ] No
As of May 14, 2009, the issuer had 1,200,773 outstanding shares of common
stock.
RIDGEFIELD ACQUISITION CORP.
FORM 10-QSB
Page
PART I FINANCIAL INFORMATION 3
Item 1. Financial Statements 3
Consolidated Balance Sheets as of March 31, 2009
(unaudited) and December 31, 2008. 3
Consolidated Statements of Operations and
Comprehensive Income for the Three Months Ended
March 31, 2009 and 2008 (unaudited). 4
Consolidated Statements of Cash Flows for the Three Months
Ended March 31, 2009 and 2008 (unaudited). 5
Notes to Condensed Consolidated Financial Statements 6
Item 2. Management Discussion and Analysis of Financial Condition
and Results of Operations 9
Item 4T. Controls and Procedures 11
PART II OTHER INFORMATION 11
Item 1. Legal Proceedings 11
Item 6. Exhibits 12
SIGNATURES 13
2
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
RIDGEFIELD ACQUISITION CORP. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
March 31, 2009 Dec. 31, 2008
(Unaudited)
-------------- -------------
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 99,263 $ 123,162
Investments 761,294 $ 626,750
----------- -----------
TOTAL ASSETS $ 860,557 $ 749,912
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses $ 16,085 $ 15,285
----------- -----------
TOTAL CURRENT LIABILITIES 16,085 15,285
----------- -----------
COMMITMENTS AND CONTINGENCIES -- --
STOCKHOLDERS' EQUITY
Preferred Stock, $.01 par value; authorized - 5,000,000 shares
Issued - none -- --
Common Stock, $.001 par value; authorized - 30,000,000 shares
Issued and outstanding - 1,200,773 shares 1,201 1,183
Capital in excess of par value 2,182,943 2,155,961
Accumulated deficit (1,789,884) (1,738,185)
Accumulated other comprehensive gain 450,212 315,668
----------- -----------
TOTAL STOCKHOLDERS' EQUITY 844,472 734,627
----------- -----------
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY $ 860,557 $ 749,912
=========== ===========
See accompanying notes to consolidated financial statements.
3
RIDGEFIELD ACQUISITION CORP. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(UNAUDITED)
Three Months Ended
March 31,
2009 2008
--------- ---------
REVENUES
Interest income $ 85 $ 901
--------- ---------
TOTAL REVENUES 85 901
--------- ---------
OPERATING EXPENSES
General and administrative 51,785 6,592
--------- ---------
TOTAL EXPENSES 51,785 6,592
--------- ---------
NET LOSS (51,700) (5,691)
OTHER COMPREHENSIVE INCOME/(LOSS)
Unrealized gain on securities 134,544 21,850
--------- ---------
OTHER COMPREHENSIVE INCOME 134,544 21,850
--------- ---------
COMPREHENSIVE INCOME $ 82,844 $ 16,159
========= =========
NET INCOME (LOSS) PER COMMON SHARE
Basic and Dilutive $ .04 $ (0.01)
========= =========
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING
Basic and Dilutive 1,188,773 1,140,773
========= =========
See accompanying notes to consolidated financial statements
4
RIDGEFIELD ACQUISITION CORP. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Three Months Ended
March 31,
2009 2008
--------- ---------
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $ (51,700) $ (5,691)
Adjustment to reconcile net loss to net cash
used in operating activities
Stock issuance for professional services 27,000 --
Changes in assets and liabilities
Increase (Decrease) in accounts payable and
accrued expenses 801 (250)
--------- ---------
Net Cash Used in Operating Activities (23,899) (5,941)
NET DECREASE IN CASH AND CASH EQUIVALENTS (23,899) (5,941)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIODS 123,162 186,287
--------- ---------
CASH AND CASH EQUIVALENTS, END OF PERIODS $ 99,263 $ 180,346
========= =========
See accompanying notes to consolidated financial statements.
5
RIDGEFIELD ACQUISITION CORP. AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The unaudited condensed consolidated financial statements included herein
were prepared pursuant to the rules and regulations of the Securities and
Exchange Commission. Certain information and footnote disclosure normally
included in financial statements prepared in accordance with accounting
principles generally accepted in the United States of America have been
condensed or omitted pursuant to such rules and regulations. In the opinion of
management, disclosures made are adequate to make the information not
misleading. These condensed consolidated financial statements should be read in
conjunction with the financial statements and notes included in the Company's
Form 10-K for the year ended December 31, 2008.
In the opinion of management, the interim data includes all adjustments,
consisting of normal recurring adjustments, necessary for a fair presentation of
the results for the interim period. The results of operations for the interim
periods are not necessarily indicative of the results that may be expected for
the fiscal year.
NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements of Ridgefield Acquisition Corp. include
the accounts of Bio-Medical Automation, Inc., its wholly-owned subsidiary. All
inter-company transactions have been eliminated in consolidation.
The accompanying financials statements as of March 31, 2009 and for the three
months then ended include the accounts of the Company and its wholly-owned
subsidiary.
In 1999, the Company sold all of its assets relating to its historical line of
business and in 2000 abandoned its research and development efforts on a
micro-robotic device. As of March 31, 2009, the Company has no principal
operations or revenue from its operations. The Company is now pursuing an
acquisition strategy whereby it is seeking to arrange for a merger, acquisition
or other business combination with a viable operating entity.
NOTE 2 - BASIS OF ACCOUNTING / GOING CONCERN
The accompanying consolidated financial statements have been prepared on the
basis of accounting principles applicable to a going concern which contemplates
the realization of assets and extinguishment of liabilities in the normal course
of business. As shown in the accompanying consolidated financial statements, the
Company has accumulated a deficit of $1,789,884 through March 31, 2009. As
discussed in Note 1, the Company, in 1999, sold all of its assets relating to
its historical line of business and abandoned, in 2000, its efforts in the
research and development of a micro-robotic device. As of March 31, 2009, the
Company has no principal operations or revenue producing activities.
These factors indicate that the Company may be unable to continue in existence.
The Company's financial statements do not include any adjustments related to the
carrying value of assets or the amount and classification of liabilities that
might be necessary should the Company be unable to continue in existence. The
Company's ability to establish itself as a going concern is dependent on its
ability to merge with another entity or acquire revenue producing activities.
Note 3 - NEW ACCOUNTING STANDARDS
There are no new accounting standards that are expected to have a significant
impact on the Company.
6
RIDGEFIELD ACQUISITION CORP. AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 4 - RELATED PARTY TRANSACTIONS
On March 28, 2006, the Company entered into a new employment agreement with Mr.
Bronson, that provides Mr. Bronson will serve as President of the Company
without an annual salary.
On June 6, 2008, the Company entered into a Consulting Agreement with Catalyst
Financial. Pursuant to the Consulting Agreement, Catalyst Financial agreed to
provide consulting services to the Company relating to the management and
administration of the Company's business affairs and in connection with the
Company's acquisition strategy, Catalyst Financial shall assist the Company in
identifying and investigating prospective target companies for mergers,
acquisitions, business combinations and similar transactions, and, if
investigation warrants, advising the Company concerning the negotiation of terms
and the financial structure of such transactions.
As consideration for the consulting services rendered and to be rendered by the
Catalyst Financial, the Company shall: (1) pay Catalyst Financial a monthly fee
in the amount of $5,000 commencing on June 6, 2008 and continuing thereafter on
the first day of each successive month until January 1, 2010, and (2) the
Company shall issue Catalyst Financial a total of 120,000 shares of the
Company's common stock, $.001 par value (the "Shares"). The Shares shall be
issued to Catalyst Financial and shall vest at a rate of 6,000 shares per month
commencing on June 30, 2008 and an additional 6,000 shares shall vest on the
last day of each successive month thereafter until January 31, 2010. Pursuant to
the Consulting Agreement, during the three months ended March 31, 2009, the
Company paid Catalyst Financial $15,000 and issued Catalyst Financial an
aggregate amount of 18,000 shares of the Company's common stock as follows: (1)
6,000 shares on January 31, 2009, (2) 6,000 shares on February 28, 2009 and (3)
6,000 shares on March 31, 2009.
NOTE 5 - INVESTMENTS
Investments are classified as available for sale according to the provisions of
Financial Accounting Standards Board Statement No. 115, "Accounting for Certain
Investments in Debt and Equity Securities." Accordingly, the investments are
carried at fair value with unrealized gains and losses reported separately in
other comprehensive income. Realized gains and losses are calculated using the
original cost of those investments. On June 1, 2007, the Company purchased
57,500 shares of Argan, Inc., a publicly traded holding company, at a price of
$5.40 per share or $311,082. These investments had a fair market value of
$761,294 and cumulative unrealized gains of $450,212 at March 31, 2009.
NOTE 6 - ASSETS AND LIABILITIES MEASURED AT FAIR VALUE
The Company has adopted Statement of Financial Accounting Standards No. 157,
Fair Value Measurements" ("SFAS No. 157"). SFAS No. 157 defines fair value,
establishes a framework for measuring fair value, and expands disclosures about
fair value measurements. SFAS No. 157 applies to reported balances that are
required or permitted to be measured at fair value under existing accounting
pronouncements; accordingly, the standard does not require any new fair value
measurements of reported balances.
SFAS No. 157 emphasizes that fair value is a market-based measurement, not an
entity- specific measurement. Therefore, a fair value measurement should be
determined based on the assumptions that market participants would use in
pricing the asset or liability. As a basis for considering market participant
assumptions in fair value measurements, SFAS No. 157 establishes a fair value
hierarchy that distinguishes between market participant assumptions based on
market data obtained from sources independent of the reporting entity
(observable inputs that are classified within Levels 1 and 2 of the hierarchy)
and the reporting entity's own assumptions about market participant assumptions
(unobservable inputs classified within Level 3 of the hierarchy).
7
RIDGEFIELD ACQUISITION CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 - ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)
Level 1 inputs utilize quoted prices (unadjusted) in active markets for
identical assets or liabilities that the Company has the ability to access.
Level 2 inputs are inputs other than quoted prices included in Level 1 that are
observable for the asset or liability, either directly or indirectly. Level 2
inputs may include quoted prices for similar assets and liabilities in active
markets, as well as inputs that are observable for the asset or liability (other
than quoted prices), such as interest rates, foreign exchange rates, and yield
curves that are observable at commonly quoted intervals. Level 3 inputs are
unobservable inputs for the asset or liability which are typically based on an
entity's own assumptions, as there is little, if any, related market activity.
In instances where the determination of the fair value measurement is based on
inputs from different levels of the fair value hierarchy, the level in the fair
value hierarchy within which the entire fair value measurement falls is based on
the lowest level input that is significant to the fair value measurement in its
entirety. The Company's assessment of the significance of a particular input to
the fair value measurement in its entirety requires judgment, and considers
factors specific to the asset liability.
Marketable Equity Securities
Currently, the Company owns 57,500 shares of common stock of Argan, Inc. (Note
5). The valuation of such stock is based on quoted prices (unadjusted) and as a
result the investments are classified within Level 1 of the fair-value
hierarchy.
Money Market Funds
Cash and cash equivalents include money market accounts valued at $99,263.
The Company has determined that the inputs associated with the fair value
determination are based on quoted prices (unadjusted) and as a result the
investments are classified within Level 1 of the fair-value hierarchy.
The table below presents the Company's assets and liabilities measured at fair
value on a recurring basis as of March 31, 2009, aggregated by the level in the
fair value hierarchy within which those measurements fall.
Assets and Liabilities Measured at Fair Value on a Recurring Basis at March 31,
2009:
Balance at
Level 1 Level 2 Level 3 March 31, 2009
------------------------------------------------
Assets
Marketable Equity Securities $761,294 $ -- $ -- $761,294
Money Market Funds $99,263 $ -- $ -- $ 99,263
The Company does not have any fair value measurements within Level 2 or Level 3
of the fair value hierarchy as of March 31, 2009.
Note 7 - SUBSEQUENT EVENT
In accordance with the Consulting Agreement, the Company paid Catalyst Financial
$5,000 on April 1, 2009 and $5,000 on May 1, 2009 and on April 30, 2009 the
Company issued 6,000 shares of the Company's common stock, $.001 par value, to
Catalyst Financial.
8
Item 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations
Forward Looking Statements Disclosure
- -------------------------------------
This report on Form 10-Q contains, in addition to historical information,
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the
"Exchange Act"). You can identify these forward-looking statements when you see
words such as "expect," "anticipate," "estimate," "may," "plans," "believe," and
other similar expressions. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties and assumptions that
are difficult to predict. Actual results could differ materially from those
projected in the forward-looking statements. Factors that could cause such a
difference include, but are not limited to, those discussed in the section
entitled "Factors Affecting Operating Results and Market Price of Stock,"
contained in the Company's Annual Report on Form 10-K for the year ended
December 31, 2008. Readers are cautioned not to place undo reliance on these
forward-looking statements, which speak only as of the date hereof. We undertake
no obligation to update any forward-looking statements.
The following discussion and analysis provides information which the
Company's management believes to be relevant to an assessment and understanding
of the Company's results of operations and financial condition. This discussion
should be read together with the Company's financial statements and the notes to
financial statements, which are included in this report, as well as the
Company's Annual Report on Form 10-K for the year ended December 31, 2008.
Acquisition Strategy
- --------------------
The Company's plan of operation is to arrange for a merger, acquisition,
business combination or other arrangement by and between the Company and a
viable operating entity. The Company has not identified a viable operating
entity for a merger, acquisition, business combination or other arrangement, and
there can be no assurance that the Company will ever successfully arrange for a
merger, acquisition, business combination or other arrangement by and between
the Company and a viable operating entity.
The Company anticipates that the selection of a business opportunity will
be a complex process and will involve a number of risks, because potentially
available business opportunities may occur in many different industries and may
be in various stages of development. Due in part to depressed economic
conditions in a number of geographic areas, rapid technological advances being
made in some industries and shortages of available capital, management believes
that there are numerous firms seeking either the limited additional capital
which the Company will have or the benefits of a publicly traded corporation, or
both. The perceived benefits of a publicly traded corporation may include
facilitating or improving the terms upon which additional equity financing may
be sought, providing liquidity for principal shareholders, creating a means for
providing incentive stock options or similar benefits to key employees,
providing liquidity for all shareholders and other factors.
In some cases, management of the Company will have the authority to effect
acquisitions without submitting the proposal to the shareholders for their
consideration. In some instances, however, the proposed participation in a
business opportunity may be submitted to the shareholders for their
consideration, either voluntarily by the Board of Directors to seek the
shareholders' advice and consent, or because of a requirement of state law to
do so.
In seeking to arrange a merger, acquisition, business combination or other
arrangement by and between the Company and a viable operating entity,
management's objective will be to obtain long-term capital appreciation for the
Company's shareholders. There can be no assurance that the Company will be able
to complete any merger, acquisition, business combination or other arrangement
by and between the Company and a viable operating entity.
The Company may need additional funds in order to effectuate a merger,
acquisition or other arrangement by and between the Company and a viable
operating entity, although there is no assurance that the Company will be able
to obtain such additional funds, if needed. Even if the Company is able to
obtain additional funds there is no assurance that the Company will be able to
effectuate a merger, acquisition or other arrangement by and between the Company
and a viable operating entity.
9
Investment Strategy
- -------------------
On August 25, 2003, the Board of Directors of the Company authorized the
Company to invest a portion of the Company's cash in marketable securities in an
effort to realize a greater rate of return than the Company had been earning in
light of historically low interest rates. The Board directed that management
maintain at least $40,000 of the Company's cash in a federally insured bank or
money market account.
In furtherance of the Company's investment strategy, the Company opened a
brokerage account with Catalyst Financial LLC ("Catalyst"), a broker-dealer
registered with the U.S. Securities and Exchange Commission and a member in good
standing with the National Association of Securities Dealers, Inc. Catalyst is
owned and controlled by Steven N. Bronson, the Company's President. Catalyst has
agreed to charge the Company commissions of no more that $.02 per share with a
minimum of $75 per trade on securities transactions. The Board approved the
commission structure to be charged by Catalyst. Mr. Bronson abstained from
voting on all Board resolutions concerning the Company's investment strategy and
the Company's arrangements with Catalyst.
On June 1, 2007, the Company purchased 57,500 shares of Argan common stock
at an average price of $5.40 per share or $311,082. At March 31, 2009 the
Company's 57,500 shares of Argan common stock were valued at $761,294.
While the Company will endeavor to invest in securities that have a
potential for gain, there can be no assurances that the Company will not suffer
losses based on its Investment Strategy.
Results of Operations
- ---------------------
For the three months ended March 31, 2009, the Company has not earned any
revenues, except for interest income of $85. For the same period the Company
incurred general and administrative expenses of $51,785 resulting in a net loss
from operations equal to $51,700. General and administrative expenses for the
three months ended March 31, 2009 which consists of costs associated primarily
with maintaining the Company's status as a public company, including, without
limitation, filing periodic reports with the United States Securities and
Exchange Commission.
Liquidity and Capital Resources
- -------------------------------
During the three months ended March 31, 2009, the Company satisfied its
working capital needs from cash on hand and cash generated from interest income
during the year. As of March 31, 2009, the Company had cash and cash equivalents
on hand in the amount of $99,263 and the Company, held 57,500 shares of Argan,
Inc.("Argan") common stock valued at $761,294.
The Company's future financial condition will be subject to: (1) its
ability to arrange for a merger, acquisition or a business combination with an
operating business on favorable terms that will result in profitability, or (2)
its ability to successfully develop and exploit the Patent. There can be no
assurance that the Company will be able to do so or, if it is able to do so,
that the transaction will be on favorable terms not resulting in an unreasonable
amount of dilution to the Company's existing shareholders.
The Company may need additional funds in order to effectuate a merger,
acquisition or other arrangement by and between the Company and a viable
operating entity, although there is no assurance that the Company will be able
to obtain such additional funds, if needed. Even if the Company is able to
obtain additional funds there is no assurance that the Company will be able to
effectuate a merger, acquisition or other arrangement by and between the Company
and a viable operating entity.
10
Item 4T. Controls and Procedures
We maintain "disclosure controls and procedures," as defined in Rules
13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that
information required to be disclosed by us in reports we file or submit under
the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the SEC's rules and forms, and that such information is
accumulated and communicated to our principal executive officer to allow timely
decisions regarding required disclosure.
Evaluation of disclosure and controls and procedures.
As of the end of the period covered by this report, the Company carried out
an evaluation, under the supervision and with the participation of our Principal
Executive Officer, of the effectiveness of the design and operation of the
Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and
15d-15(e) under the Exchange Act). Based on the evaluation, the Company's
Principal Executive Officer has concluded that the Company's disclosure controls
and procedures are designed to provide reasonable assurance that information
required to be disclosed by the Company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and reported within
the time periods specified in the SEC's rules and forms and are operating in an
effective manner.
Changes in internal controls over financial reporting.
There have been no changes in Company's internal control over financial
reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act)
that occurred during Company's most recent quarter that has materially affected,
or is reasonably likely to materially affect, Company's internal control over
financial reporting.
It should be noted that any system of controls, however well designed and
operated, can provide only reasonable, and not absolute, assurance that the
objectives of the system are met. In addition, the design of any control system
is based in part upon certain assumptions about the likelihood of future events.
Because of these and other inherent limitations of control systems, there is
only reasonable assurance that the Company's controls will succeed in achieving
their stated goals under all potential future conditions.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
During the quarter ended March 31, 2009, the Company was not a party to any
material legal proceedings.
11
Item 5. Other Information
On June 3, 2008, the Board of Directors duly authorized and approved the
Company's entry into a consulting agreement with Steven N. Bronson abstained
from the vote.
On June 6, 2008, the Company entered into an agreement with Catalyst
Financial LLC ("Catalyst Financial"), a full service securities brokerage,
investment banking and consulting firm, owned by Steven N. Bronson, the
President and Chairman of the Company. (the "Consulting Agreement"). Pursuant to
the Consulting Agreement, Catalyst Financial agreed to provide consulting
services to the Company relating to the management and administration of the
Company's business affairs and in connection with the Company's acquisition
strategy.
In consideration for the consulting services rendered and to be rendered by
the Catalyst Financial, the Company shall: (1) pay Catalyst Financial a monthly
fee in the amount of $5,000 commencing on June 6, 2008 and continuing thereafter
on the first day of each successive month until January 1, 2010, and (2) the
Company shall issue Catalyst Financial a total of 120,000 shares of the
Company's common stock, $.001 par value (the "Shares"). The Shares shall be
issued to Catalyst Financial and shall vest at a rate of 6,000 shares per month
commencing on June 30, 2008 and an additional 6,000 shares shall vest on the
last day of each successive month thereafter until January 31, 2010. The above
is just a summary of the Consulting Agreement, readers are referred to the
actual Consulting Agreement for all of its terms and conditions. A copy of the
Consulting Agreement is attached as Exhibit 10.19 to a Form 8-K, dated June 9,
2008.
Pursuant to the Consulting Agreement, during the three months ended March
31, 2009, the Company paid Catalyst Financial $15,000 and issued Catalyst
Financial an aggregate amount of 18,000 shares of the Company's common stock as
follows: (1) 6,000 shares on January 31, 2009, (2) 6,000 shares on February 28,
2009 and (3) 6,000 shares on March 31, 2009.
Subsequent Event
- ----------------
In accordance with the Consulting Agreement, the Company paid Catalyst
Financial $5,000 on April 1, 2009 and $5,000 on May 1, 2009 and on April 30,
2009 the Company issued 6,000 shares of the Company's common stock, $.001 par
value, to Catalyst Financial.
Item 6. Exhibits
The following exhibits are hereby filed as part of this Quarterly
Report on Form 10-QSB or incorporated herein by reference.
3.1 Articles of Incorporation, incorporated by reference to Registration
Statement No. 33-13074-D as Exhibit 3.1.
3.2 Amended Bylaws adopted June 1, 1987, incorporated by reference to
Annual Report on Form 10-K for the fiscal year ended December 31, 1987
as Exhibit 3.2.
3.4 Articles of Amendment to Restated Articles of Incorporation dated
March 7,1991. Incorporated by reference to Annual Report on Form 10-K
for fiscal year ended December 31, 1990 as Exhibit 3.4.
3.5 Articles of Amendment to Restated Articles of Incorporation dated
March 17, 1999, incorporated by reference to the Company's Current
Report on Form 8-K reporting an event of March 9, 1999.
3.6 Articles of Incorporation of Bio-Medical Automation, Inc. a Nevada
corporation, the Company's wholly owned subsidiary.
3.7 By-laws of Bio-Medical Automation, Inc. a Nevada corporation, the
Company's wholly owned subsidiary.
10.1 OEM Purchase Agreement dated January 15, 1990, between the Company and
Ariel Electronics, Inc. incorporated by reference to Annual Report on
Form 10-K for the fiscal year ended December 31, 1989 as Exhibit 10.1.
10.2 Form of Convertible Promissory Note, 12/30/93 Private Placement
incorporated by reference to Annual Report on Form 10-KSB for the
fiscal year ended December 31, 1993 as Exhibit 10.2.
12
10.3 Form of Non-Convertible Promissory Note, 12/30/93 Private Placement
incorporated by reference to Annual Report on Form 10-KSB for the
fiscal year ended December 31, 1993 as Exhibit 10.3.
10.4 Form of Note Purchaser Warrant Agreement and Warrant, 12/30/93 Private
Placement incorporated by reference to Annual Report on Form 10-KSB
for the fiscal year ended December 31, 1993 as Exhibit 10.4.
10.5 Form of Promissory Note, April 1, 1996.
10.6 Form of Security Agreement, April 1, 1996.
10.7 Form of Common Stock Purchase Warrant, April 1, 1996.
10.8 Form of Promissory Note, July 1, 1996.
10.9 Form of April 1, 1996 Promissory Note Extension, October 17, 1996.
10.10 Form of Common Stock Purchase Warrant, October 10, 1996.
10.11 Asset Purchase Agreement with JOT incorporated by reference to Form
8-K reporting an event of November 4, 1998, and amendment thereto
incorporated by reference to Form 8-K reporting an event of December
15, 1998.
10.12 Stock Purchase Agreement, between Bio-Medical Automation, Inc. and
Steven N. Bronson, incorporated by reference to the Current Report on
Form 8-K filed on April 6, 2000.
10.13 Employment Agreement between Bio-Medical Automation, Inc. and Steven
N. Bronson, dated as of March 24, 2001, incorporated by reference to
Quarterly Report on Form 10-QSB for the quarter ended March 31, 2001.
10.14 Mergers and Acquisitions Advisory Agreement, dated as of November 13,
2001, between Bio-Medical Automation, Inc. and Catalyst Financial LLC
incorporated by reference to the Annual Report on Form 10-KSB for the
year ended December 31, 2001.
10.15 Mergers and Acquisitions Advisory Agreement, dated as of April 1,
2005, between Ridgefield Acquisition Corp. and Catalyst Financial LLC.
10.16 Appointment of Atlas Stock Transfer Agent Corporation as the transfer
Agent for Ridgefield Acquisition Corp.
10.17 Employment Agreement between Ridgefield Acquisition Corp. and Steven
N. Bronson, dated as of March 28, 2006.
10.18 Addendum, dated as of February 1, 2006, to Mergers and Acquisitions
Advisory Agreement, dated as of April 1, 2005, between Ridgefield
Acquisition Corp. and Catalyst Financial LLC.
14 Code of Ethics
31* President's Written Certification Of Financial Statements Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
32* President's Written Certification Of Financial Statements Pursuant to
18 U.S.C. Statute 1350.
- --------------------------------
* Filed herewith
SIGNATURES
In accordance with the requirements of the Exchange Act, the Registrant
caused this Report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Dated: May 14, 2009
RIDGEFIELD ACQUSITION CORP.
By: /s/ Steven N. Bronson
------------------------------------
Steven N. Bronson, President
(Principle Executive Officer),
as Registrant's duly authorized
officer
13
EXHIBIT INDEX
The following Exhibits are filed herewith:
Exhibit
Number Description of Document
- ------ -----------------------
31 President's Statement Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
32 President's Written Certification Of Financial Statements Pursuant
to 18 U.S.C. Statute 1350.